The Quick Answer
Both semaglutide and tirzepatide are highly effective GLP-1 medications for medical weight loss. Clinical trials show tirzepatide produces slightly greater average weight loss (~20% body weight vs ~15% for semaglutide), but semaglutide has a longer track record and may be better tolerated by some patients. Both are excellent options — the best choice depends on your goals, health history, and budget.
For med spa owners
See how complete and readable your listing is
Your free AI Visibility Score checks your listing’s public information and machine readability. It does not query AI assistants. Claim your free listing to update your business details.
What Are These Medications?
Both drugs belong to a class called GLP-1 receptor agonists — they mimic hormones that regulate appetite and blood sugar, helping you feel full sooner and eat less.
- Semaglutide (brand names: Ozempic for diabetes, Wegovy for weight loss) — activates GLP-1 receptors only. Originally developed for type 2 diabetes, now widely used for weight management.
- Tirzepatide (brand names: Mounjaro for diabetes, Zepbound for weight loss) — activates both GLP-1 and GIP receptors (dual agonist). The dual mechanism is believed to explain its greater efficacy.
Efficacy Comparison
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Average weight loss | ~15% body weight | ~20% body weight |
| FDA approval (weight loss) | Yes (Wegovy, 2021) | Yes (Zepbound, 2023) |
| Mechanism | GLP-1 only | GLP-1 + GIP dual |
| Injection frequency | Once weekly | Once weekly |
| Time to max results | 12–18 months | 12–18 months |
| Years on market | 5+ years | 2+ years |
Side Effects: Which Has Fewer?
Both medications share similar GI side effects — nausea, vomiting, diarrhea, and constipation — especially when starting or increasing doses. These typically improve significantly after 4–8 weeks as your body adjusts.
- Semaglutide: GI side effects reported in ~40–45% of patients, usually mild-moderate
- Tirzepatide: Slightly higher GI side effect rate at higher doses, but similar long-term tolerability
- Both carry rare risks of pancreatitis and thyroid tumors — your provider will monitor accordingly
Your med spa provider will use a slow dose titration protocol to minimize side effects.
Cost Comparison at Med Spas
| Medication | Med Spa (Compound) | Brand Name |
|---|---|---|
| Semaglutide | $299–$499/month | $900–$1,400/month (Wegovy) |
| Tirzepatide | $399–$599/month | $650–$1,000/month (Zepbound) |
Compounded versions use the same active molecule, manufactured by FDA-registered compounding pharmacies. They are not FDA-approved drugs but are widely prescribed when brand-name supply is limited.
Which Should You Choose?
Use this decision framework:
- Budget is the priority → Semaglutide compound ($299–$499/mo) is typically $100/mo cheaper than tirzepatide
- Maximum weight loss matters most → Tirzepatide's dual mechanism produces ~5% more weight loss on average
- You have type 2 diabetes → Discuss with your provider; both were developed for diabetes management
- You're sensitive to GI side effects → Start with semaglutide at lowest dose, with careful titration
- You've tried semaglutide without success → Tirzepatide's different mechanism may work better for you
Where to Get GLP-1 Treatment
Both medications are available at thousands of med spas across the US. Many providers offer telehealth consultations with same-week prescription turnaround.
Find verified GLP-1 providers near you: GLP-1 Weight Loss at Med Spas: Complete Guide or browse semaglutide providers by city.